The Czech Association of Innovative Pharmaceutical Industry, under the auspices of the Czech Presidency of the Council of the EU, organized a major face-to-face international conference on the topic of Pharmaceutical strategy for Europe that was held at the premises of the Permanent Representation of the Czech Republic to the European Union.

The speakers were:
Jakub Dvořáček, Ministry of Health, Czech Republic
David Kolář, Association of Innovative Pharmaceutical Industry, Czech Republic
Anthony Rodiadis, European Commission
Kateřina Konečná, European Parliament
Irena Storová, State Institute for Drug Control, Czech Republic
Nathalie Moll, European Federation of Pharmaceutical Industries and Associations
Sini Eskola, European Federation of Pharmaceutical Industries and Associations
Ansgar Hebborn, European Federation of Pharmaceutical Industries and Associations
Pavel Sedláček, Association of Innovative Pharmaceutical Industry, Czech Republic

Chapters:
0:00 – Introduction
3:46 – Jakub Dvořáček – Welcome Address
12:48 – David Kolář – Meeting in the Senate of the Czech Republic on 7 June: Summary and Recommendations
21:37 – Introduction of the First Session
22:16 – Anthony Rodiadis – New Pharmaceutical Legislation for the EU: Vision for Future Development
31:10 – Kateřina Konečná – View of the European Parliament on the Development of New Pharmaceutical Legislation
40:43 – Irena Storová – Recent Approaches Towards Early Access of EU Patients to Innovative Therapies: Pre-Marketing Authorisation Perspective
53:41 – Nathalie Moll – Expectations of the Innovative Pharmaceutical Industry Regarding the Revision of the Pharmaceutical Legislation
1:16:08 – Discussion
1:38:43 – Introduction of the Second Session
1:40:54 – Sini Eskola – How to Future-proof the Pharmaceutical Legislation in Europe: Key Regulatory Priorities for the Innovative Industry
1:57:53 – Ansgar Hebborn – EU HTA: Adding Value to the Future Evaluation of Innovative Medicines
2:12:41 – Jakub Dvořáček – European Health Data Space and Its Importance for Providing New Technologies to EU Patients
2:25:31 – Discussion
3:02:00 – Pavel Sedláček – Industry Engagement in the New Pharmaceutical Legislation
3:08:18 – Jakub Dvořáček – Czech Presidency's View on the Development of New Pharmaceutical Legislation

свернуть